Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical vs Intravenous Tranexamic Acid in TKA
NCT02323373Phase 2Completed
- Sponsor
- Santa Casa de Misericórdia de São Paulo
- Start
- Jun 2014
- Primary completion
- Nov 2014
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, single-blind trial of tranexamic acid in osteoarthritis (OA) (3 arms), sponsored by Santa Casa de Misericórdia de São Paulo. Primary endpoint: Blood loss at 48 hours. Started Jun 2014; status: completed.
02
Drugs
tranexamic acid
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02323373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02323373.